Soleno Therapeutics (SLNO) Other Gross PP&E Adjustments (2013 - 2026)
Soleno Therapeutics (SLNO) reported Other Gross PP&E Adjustments of -$7.8 million for Q1 2026, down 199.5% year-over-year from $7.8 million in Q1 2025, and down 105.97% on a QoQ basis from -$3.8 million in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Other Gross PP&E Adjustments data on file, last reported at -$7.8 million in Q1 2026.
- Quarterly Other Gross PP&E Adjustments fell 199.5% year-over-year to -$7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.8 million (down 199.5% YoY) and the FY2025 annual result came in at -$3.8 million, up 66.11% from the prior year.
- Other Gross PP&E Adjustments retreated to -$7.8 million in Q1 2026 per SLNO's latest filing, from -$3.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$53000.0 in Q1 2023 and bottomed at -$11.2 million in Q4 2024.
- The 5-year median for Other Gross PP&E Adjustments is -$2.3 million (2023), against an average of -$2.6 million.
- The widest annual swing landed in 2022, when Other Gross PP&E Adjustments sank 2592.31%; it then jumped 84.86% in 2023.
- Tracing SLNO's Other Gross PP&E Adjustments over 5 years: stood at -$2.7 million in 2022, then increased by 14.49% to -$2.3 million in 2023, then tumbled by 381.67% to -$11.2 million in 2024, then surged by 66.11% to -$3.8 million in 2025, then plunged by 105.97% to -$7.8 million in 2026.
- Per Business Quant, the three latest SLNO Other Gross PP&E Adjustments figures stand at -$7.8 million (Q1 2026), -$3.8 million (Q4 2025), and -$5.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | -7.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.80 Mn |
| Mar 31, 2026 | -7.80 Mn |
| Dec 31, 2025 | -3.79 Mn |
| Dec 31, 2025 | -3.79 Mn |
| Sep 30, 2025 | -5.78 Mn |
| Sep 30, 2025 | -5.78 Mn |
| Jun 30, 2025 | -2.43 Mn |
| Jun 30, 2025 | -2.43 Mn |
| Mar 31, 2025 | -2.60 Mn |
| Mar 31, 2025 | -2.60 Mn |
| Dec 31, 2024 | -11.17 Mn |
| Dec 31, 2024 | -11.17 Mn |
| Sep 30, 2024 | -2.99 Mn |
| Sep 30, 2024 | -2.99 Mn |
| Jun 30, 2024 | -268,000.00 |
| Jun 30, 2024 | -268,000.00 |
| Mar 31, 2024 | -338,000.00 |
| Mar 31, 2024 | -338,000.00 |
| Dec 31, 2023 | -2.32 Mn |
| Dec 31, 2023 | -2.32 Mn |
| Sep 30, 2023 | -474,000.00 |
| Sep 30, 2023 | -474,000.00 |
| Jun 30, 2023 | -541,000.00 |
| Jun 30, 2023 | -541,000.00 |
| Mar 31, 2023 | -53,000.00 |
| Mar 31, 2023 | -53,000.00 |
| Dec 31, 2022 | -2.71 Mn |
| Dec 31, 2022 | -2.71 Mn |
| Sep 30, 2022 | -206,000.00 |
| Sep 30, 2022 | -206,000.00 |
| Jun 30, 2022 | -279,000.00 |
| Jun 30, 2022 | -279,000.00 |
| Mar 31, 2022 | -350,000.00 |
| Mar 31, 2022 | -350,000.00 |
| Dec 31, 2021 | -1.45 Mn |
| Dec 31, 2021 | -1.45 Mn |
| Sep 30, 2021 | -489,000.00 |
| Sep 30, 2021 | -489,000.00 |
| Jun 30, 2021 | -600,000.00 |
| Jun 30, 2021 | -600,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Dec 31, 2020 | -407,000.00 |
| Dec 31, 2020 | -407,000.00 |
| Sep 30, 2020 | -195,000.00 |
| Sep 30, 2020 | -195,000.00 |
| Jun 30, 2020 | -265,000.00 |
| Jun 30, 2020 | -265,000.00 |
| Mar 31, 2020 | -22,000.00 |
| Mar 31, 2020 | -22,000.00 |
| Dec 31, 2019 | -56,000.00 |
| Dec 31, 2019 | -56,000.00 |
| Dec 31, 2018 | 35,000.00 |
| Dec 31, 2018 | 35,000.00 |
| Dec 31, 2017 | 61,000.00 |
| Dec 31, 2017 | 61,000.00 |
| Dec 31, 2016 | 92,450.00 |
| Dec 31, 2016 | 92,450.00 |
| Dec 31, 2015 | 297,595.00 |
| Dec 31, 2015 | 297,595.00 |
| Dec 31, 2014 | 218,519.00 |
| Dec 31, 2014 | 218,519.00 |
| Sep 30, 2014 | 139,695.00 |
| Sep 30, 2014 | 139,695.00 |
| Dec 31, 2013 | 218,519.00 |
| Dec 31, 2013 | 218,519.00 |